{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T07:53:18Z","timestamp":1776153198216,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 114\\u20132314-B-A49\\u2013075-MY3"],"award-info":[{"award-number":["NSTC 114\\u20132314-B-A49\\u2013075-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.lfs.2026.124325","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T10:06:43Z","timestamp":1773828403000},"page":"124325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["CCL7 suppression alleviates vascular injury by blocking the CCR5\/STAT1 signaling pathway in chronic kidney disease"],"prefix":"10.1016","volume":"393","author":[{"given":"Hsin-Jou","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng-Yen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaw-Wen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4116-7029","authenticated-orcid":false,"given":"Ting-Ting","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.lfs.2026.124325_bb0005","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41581-024-00820-6","article-title":"Chronic kidney disease and the global public health agenda: an international consensus","volume":"20","author":"Francis","year":"2024","journal-title":"Nat. Rev. Nephrol."},{"issue":"Suppl. 6","key":"10.1016\/j.lfs.2026.124325_bb0010","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/dom.15747","article-title":"Cardiovascular and non-renal complications of chronic kidney disease: managing risk","volume":"26","author":"Rossing","year":"2024","journal-title":"Diabetes Obes. Metab."},{"issue":"13","key":"10.1016\/j.lfs.2026.124325_bb0015","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1001\/jama.2019.14745","article-title":"Chronic kidney disease diagnosis and management: a review","volume":"322","author":"Chen","year":"2019","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.lfs.2026.124325_bb0020","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1161\/CIRCULATIONAHA.113.007106","article-title":"Risk of end-stage renal disease and death after cardiovascular events in chronic kidney disease","volume":"130","author":"Sud","year":"2014","journal-title":"Circulation"},{"issue":"21","key":"10.1016\/j.lfs.2026.124325_bb0025","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1001\/jama.2021.2126","article-title":"Lower extremity peripheral artery disease without chronic limb-threatening ischemia: a review","volume":"325","author":"Polonsky","year":"2021","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.lfs.2026.124325_bb0030","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1053\/j.ajkd.2019.10.006","article-title":"Peripheral artery disease in CKD: anatomically peripheral but clinically central","volume":"75","author":"Hishida","year":"2020","journal-title":"Am. J. Kidney Dis."},{"issue":"4","key":"10.1016\/j.lfs.2026.124325_bb0035","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1053\/j.ajkd.2012.02.340","article-title":"Peripheral artery disease and CKD: a focus on peripheral artery disease as a critical component of CKD care","volume":"60","author":"Garimella","year":"2012","journal-title":"Am. J. Kidney Dis."},{"issue":"10075","key":"10.1016\/j.lfs.2026.124325_bb0040","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/S0140-6736(16)32064-5","article-title":"Chronic kidney disease","volume":"389","author":"Webster","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2026.124325_bb0045","doi-asserted-by":"crossref","first-page":"1500336","DOI":"10.3389\/fendo.2025.1500336","article-title":"Protein-bound uremic toxins as therapeutic targets for cardiovascular, kidney, and metabolic disorders","volume":"16","author":"Zhang","year":"2025","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"6","key":"10.1016\/j.lfs.2026.124325_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/toxins17060295","article-title":"From physicochemical classification to multidimensional insights: a comprehensive review of uremic toxin research","volume":"17","author":"Cozzolino","year":"2025","journal-title":"Toxins (Basel)"},{"issue":"1","key":"10.1016\/j.lfs.2026.124325_bb0055","doi-asserted-by":"crossref","DOI":"10.1172\/JCI155860","article-title":"Indoxyl sulfate in uremia: an old idea with updated concepts","volume":"132","author":"Berg","year":"2022","journal-title":"J. Clin. Invest."},{"issue":"11","key":"10.1016\/j.lfs.2026.124325_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/toxins12110696","article-title":"Indoxyl sulfate and incident peripheral artery disease in hemodialysis patients","volume":"12","author":"Lin","year":"2020","journal-title":"Toxins (Basel)"},{"issue":"2","key":"10.1016\/j.lfs.2026.124325_bb0065","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1161\/CIRCRESAHA.123.322875","article-title":"Activation of the aryl hydrocarbon receptor in muscle exacerbates ischemic pathology in chronic kidney disease","volume":"133","author":"Balestrieri","year":"2023","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.lfs.2026.124325_bb0070","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.kint.2015.11.020","article-title":"Indoxyl sulfate suppresses endothelial progenitor cell-mediated neovascularization","volume":"89","author":"Hung","year":"2016","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.lfs.2026.124325_bb0075","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1359-6101(99)00005-2","article-title":"The MCP\/eotaxin subfamily of CC chemokines","volume":"10","author":"Van Coillie","year":"1999","journal-title":"Cytokine Growth Factor Rev."},{"issue":"1","key":"10.1016\/j.lfs.2026.124325_bb0080","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1084\/jem.176.1.59","article-title":"Structural and functional identification of two human, tumor-derived monocyte chemotactic proteins (MCP-2 and MCP-3) belonging to the chemokine family","volume":"176","author":"Van Damme","year":"1992","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.lfs.2026.124325_bb0085","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s12933-022-01626-1","article-title":"CCL7 as a novel inflammatory mediator in cardiovascular disease, diabetes mellitus, and kidney disease","volume":"21","author":"Chang","year":"2022","journal-title":"Cardiovasc. Diabetol."},{"issue":"10","key":"10.1016\/j.lfs.2026.124325_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047464","article-title":"Bindarit inhibits human coronary artery smooth muscle cell proliferation, migration and phenotypic switching","volume":"7","author":"Maddaluno","year":"2012","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.lfs.2026.124325_bb0095","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/s41419-019-1757-0","article-title":"Hypoxia inducible factor 1alpha in vascular smooth muscle cells promotes angiotensin II-induced vascular remodeling via activation of CCL7-mediated macrophage recruitment","volume":"10","author":"Qi","year":"2019","journal-title":"Cell Death Dis."},{"issue":"763","key":"10.1016\/j.lfs.2026.124325_bb0100","doi-asserted-by":"crossref","first-page":"eadn1507","DOI":"10.1126\/scitranslmed.adn1507","article-title":"Inhibition of CCL7 improves endothelial dysfunction and vasculopathy in mouse models of diabetes mellitus","volume":"16","author":"Chang","year":"2024","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.lfs.2026.124325_bb0105","doi-asserted-by":"crossref","first-page":"14010","DOI":"10.1038\/s41598-019-50422-7","article-title":"Inhibition of Kirsten-Ras reduces fibrosis and protects against renal dysfunction in a mouse model of chronic folic acid nephropathy","volume":"9","author":"Newbury","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2026.124325_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104509","article-title":"Hydralazine improves ischemia-induced neovasculogenesis via xanthine-oxidase inhibition in chronic renal insufficiency","volume":"151","author":"Chang","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"3","key":"10.1016\/j.lfs.2026.124325_bb0115","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/jcla.20456","article-title":"P-Cresylsulfate and indoxyl sulfate level at different stages of chronic kidney disease","volume":"25","author":"Lin","year":"2011","journal-title":"J. Clin. Lab. Anal."},{"issue":"6","key":"10.1016\/j.lfs.2026.124325_bb0120","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.3390\/toxins6061742","article-title":"Differential effects of indoxyl sulfate and inorganic phosphate in a murine cerebral endothelial cell line (bEnd.3)","volume":"6","author":"Stinghen","year":"2014","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.lfs.2026.124325_bb0125","article-title":"Chronic kidney disease as an independent risk factor for chronic lower extremity ulcers: a cross-sectional analysis of US adults","volume":"22","author":"Gao","year":"2025","journal-title":"Int J Low Extrem Wounds"},{"issue":"9","key":"10.1016\/j.lfs.2026.124325_bb0130","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1681\/ASN.2013101062","article-title":"The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: a systematic review","volume":"25","author":"Vanholder","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.lfs.2026.124325_bb0135","doi-asserted-by":"crossref","DOI":"10.1172\/JCI142260","article-title":"Tryptophan metabolites suppress the Wnt pathway and promote adverse limb events in chronic kidney disease","volume":"132","author":"Arinze","year":"2022","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.lfs.2026.124325_bb0140","doi-asserted-by":"crossref","first-page":"F639","DOI":"10.1152\/ajprenal.00398.2021","article-title":"Comparison of the surgical resection and infarct 5\/6 nephrectomy rat models of chronic kidney disease","volume":"322","author":"Adam","year":"2022","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"4","key":"10.1016\/j.lfs.2026.124325_bb0145","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/ame2.12194","article-title":"Folic acid-induced animal model of kidney disease","volume":"4","author":"Yan","year":"2021","journal-title":"Animal models and experimental medicine"},{"key":"10.1016\/j.lfs.2026.124325_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108142","article-title":"IRF-4 deficiency reduces inflammation and kidney fibrosis after folic acid-induced acute kidney injury","volume":"100","author":"Chen","year":"2021","journal-title":"Int. Immunopharmacol."},{"issue":"4","key":"10.1016\/j.lfs.2026.124325_bb0155","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1046\/j.1365-2567.2000.00016.x","article-title":"Transcriptional and post-transcriptional regulation of monocyte chemoattractant protein-3 gene expression in human endothelial cells by phorbol ester and cAMP signalling","volume":"99","author":"Kondo","year":"2000","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.lfs.2026.124325_bb0160","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.acvd.2012.09.003","article-title":"The effect of tissue factor pathway inhibitor on the expression of monocyte chemotactic protein-3 and IkappaB-alpha stimulated by tumour necrosis factor-alpha in cultured vascular smooth muscle cells","volume":"106","author":"Zhao","year":"2013","journal-title":"Arch. Cardiovasc. Dis."},{"issue":"2","key":"10.1016\/j.lfs.2026.124325_bb0165","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1089\/dna.1997.16.173","article-title":"Structural and functional analysis of the promoter region of the human MCP-3 gene: transactivation of expression by novel recognition sequences adjacent to the transcription initiation site","volume":"16","author":"Murakami","year":"1997","journal-title":"DNA Cell Biol."},{"issue":"10","key":"10.1016\/j.lfs.2026.124325_bb0170","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1038\/nm.3284","article-title":"B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction","volume":"19","author":"Zouggari","year":"2013","journal-title":"Nat. Med."},{"issue":"15","key":"10.1016\/j.lfs.2026.124325_bb0175","doi-asserted-by":"crossref","first-page":"7280","DOI":"10.1111\/jcmm.16757","article-title":"CCL7 contributes to angiotensin II-induced abdominal aortic aneurysm by promoting macrophage infiltration and pro-inflammatory phenotype","volume":"25","author":"Xie","year":"2021","journal-title":"J. Cell. Mol. Med."},{"issue":"1","key":"10.1016\/j.lfs.2026.124325_bb0180","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.atherosclerosis.2011.04.002","article-title":"Monocyte chemotactic protein-3 induces human coronary smooth muscle cell proliferation","volume":"217","author":"Maddaluno","year":"2011","journal-title":"Atherosclerosis"},{"issue":"38","key":"10.1016\/j.lfs.2026.124325_bb0185","article-title":"Endothelial-derived CCL7 promotes macrophage polarization and aggravates septic acute lung injury via CCR1-mediated STAT1 succinylation","volume":"12","author":"Li","year":"2025","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.lfs.2026.124325_bb0190","doi-asserted-by":"crossref","first-page":"1345779","DOI":"10.3389\/fphar.2024.1345779","article-title":"Regulation of inflammation during wound healing: the function of mesenchymal stem cells and strategies for therapeutic enhancement","volume":"15","author":"Gao","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.lfs.2026.124325_bb0195","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.immuni.2016.02.015","article-title":"Macrophages in tissue repair, regeneration, and fibrosis","volume":"44","author":"Wynn","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.lfs.2026.124325_bb0200","doi-asserted-by":"crossref","first-page":"rbae032","DOI":"10.1093\/rb\/rbae032","article-title":"Biomaterials for immunomodulation in wound healing","volume":"11","author":"Wang","year":"2024","journal-title":"Regener. Biomater."},{"issue":"1","key":"10.1016\/j.lfs.2026.124325_bb0205","doi-asserted-by":"crossref","DOI":"10.1093\/cei\/uxaf002","article-title":"B cells recruitment promotes M2 macrophage polarization to inhibit inflammation during wound healing","volume":"219","author":"Yin","year":"2025","journal-title":"Clin. Exp. Immunol."},{"issue":"4","key":"10.1016\/j.lfs.2026.124325_bb0210","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1161\/HYPERTENSIONAHA.123.21888","article-title":"Role of the CCL5 and its receptor, CCR5, in the genesis of aldosterone-induced hypertension, vascular dysfunction, and end-organ damage","volume":"81","author":"Costa","year":"2024","journal-title":"Hypertension"},{"key":"10.1016\/j.lfs.2026.124325_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114859","article-title":"CCR5 antagonist treatment inhibits vascular injury by regulating NADPH oxidase 1","volume":"195","author":"Singh","year":"2022","journal-title":"Biochem. Pharmacol."},{"issue":"5","key":"10.1016\/j.lfs.2026.124325_bb0220","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1080\/15548627.2022.2139920","article-title":"Ablation of endothelial Atg7 inhibits ischemia-induced angiogenesis by upregulating Stat1 that suppresses Hif1a expression","volume":"19","author":"Yao","year":"2023","journal-title":"Autophagy"},{"issue":"4","key":"10.1016\/j.lfs.2026.124325_bb0225","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1681\/ASN.2015010079","article-title":"Three-dimensional morphology by multiphoton microscopy with clearing in a model of cisplatin-induced CKD","volume":"27","author":"Torres","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"issue":"11","key":"10.1016\/j.lfs.2026.124325_bb0230","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/ki.2009.86","article-title":"Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy","volume":"75","author":"Chevalier","year":"2009","journal-title":"Kidney Int."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320526001347?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320526001347?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T07:04:21Z","timestamp":1776150261000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320526001347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":46,"alternative-id":["S0024320526001347"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2026.124325","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CCL7 suppression alleviates vascular injury by blocking the CCR5\/STAT1 signaling pathway in chronic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2026.124325","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124325"}}